Twin-to-Twin Transfusion Syndrome Workup
- Author: Terence Zach, MD; Chief Editor: Ronald M Ramus, MD more...
Laboratory Studies
After delivery, the newborn work-up should include the following:
- CBC count: The donor twin is frequently anemic at birth, whereas the recipient twin is frequently polycythemic at birth.
- Calcium: Hypocalcemia is frequently present in the donor twin.
- Glucose: Hypoglycemia may be present in either twin.
- Creatinine: Either twin may have evidence of renal dysfunction.
- Platelet count: Thrombocytopenia can occur in either twin.
- Bilirubin: Hyperbilirubinemia may develop in the polycythemic recipient twin.
Imaging Studies
- Sonographic findings of TTTS during pregnancy include the following:
- Significant discrepancy in size of same-sex fetuses
- Monochorionic placentation
- Significant disparity in the amount of amniotic fluid between the fetuses with the smaller twin having oligohydramnios
- Smaller fetus with an absent stomach and bladder
- These pregnancies are at risk for preterm delivery. This may be related to the uterine overdistention from the twin gestation and polyhydramnios. Cervical shortening is also more common so transvaginal assessment of the cervix should also be done.[2]
- Neonatal imaging should include:
- Neonatal brain ultrasonography: Because ischemia of the brain can occur during fetal development in either the donor or recipient twin, brain ultrasonography should be considered in both twins born with TTTS. Twins born prematurely are susceptible to intraventricular hemorrhage and periventricular leukomalacia.
- Neonatal echocardiography: Myocardial dysfunction, myocardial hypertrophy, valvular insufficiency, and pericardial effusions can be detected in either twin.
- Neonatal renal ultrasonography: Abnormal renal echogenicity may be present in either twin and indicates hypoxic-ischemic cortical necrosis.
- Neonatal abdominal ultrasonography: Ascites may be present if hydrops fetalis occurs.
- Neonatal chest radiography: Pleural effusions and cardiomegaly may be present if hydrops fetalis occurs.
Other Tests
The risk for aneuploidy in monochorionic twin gestations is not increased compared with a singleton gestation of the same age. Invasive procedures to salvage the pregnancy would not be recommended if lethal aneuploidy (ie, T13 or T18) is seen, so evaluation of the amniotic fluid should be offered to assess for aneuploidy.[3]
Procedures
Amnioreduction can be done immediately once the diagnosis of TTTS is made. This can be performed by placing a 20- or 18-gauge spinal needle into the amniotic cavity of the fetus with polyhydramnios under ultrasonographic guidance and connecting this to 1 L evacuated containers. Several liters of fluid can be removed by this method.
The patient should then be followed weekly to evaluate for evidence of improvement, ie, monitoring the amniotic fluid volume of both fetuses. If there was some improvement in the amniotic fluid of the donor, then repeat amnioreductions can be performed if and when the polyhydramnios recurs around the recipient.
Serial ultrasonography to assess fetal growth are also recommended and these can be done every 2-4 weeks. Once an advanced gestation is obtained nonstress testing can be performed to assess fetal well-being.
If there is any evidence of cardiac failure, ie, cardiac hypertrophy or hydrops, in either fetus or if there is no response to the amnioreduction, then the patient should be referred to a center that can perform fetoscopic laser photocoagulation of the placenta.
A systematic review and meta-analysis by Rossi et al found that a small number of cases with laser therapy are affected with neurologic impairment (cerebral palsy being the most frequent) , signs of which begin in infancy. All infants, even those who appear to be healthy, should be closely followed.[4]
Staging
The most useful staging system for TTTS was developed by Quintero:[5]
Table. TTTS Staging System (Open Table in a new window)
| Stage | Oligohydramnios/ Polyhydramnios | Absent Urine in Donor Bladder | Abnormal Doppler Blood Flows | Hydrops Fetalis | Fetal Demise |
| I | + | - | - | - | - |
| II | + | + | - | - | - |
| III | + | + | + | - | - |
| IV | + | + | + | + | - |
| V | + | + | + | + | + |
[Best Evidence] O'Donoghue K, Rutherford MA, Engineer N, Wimalasundera RC, Cowan FM, Fisk NM. Transfusional fetal complications after single intrauterine death in monochorionic multiple pregnancy are reduced but not prevented by vascular occlusion. BJOG. May 2009;116(6):804-12. [Medline].
Robyr R, Boulvain M, Lewi L, Huber A, Hecher K, Deprest J, et al. Cervical length as a prognostic factor for preterm delivery in twin-to-twin transfusion syndrome treated by fetoscopic laser coagulation of chorionic plate anastomoses. Ultrasound Obstet Gynecol. Jan 2005;25(1):37-41. [Medline].
O'Brien BM. MFM/geneticist view on prenatal management of twins. Am J Med Genet C Semin Med Genet. May 15 2009;151C(2):155-61. [Medline].
Rossi AC, Vanderbilt D, Chmait RH. Neurodevelopmental outcomes after laser therapy for twin-twin transfusion syndrome: a systematic review and meta-analysis. Obstet Gynecol. Nov 2011;118(5):1145-50. [Medline].
Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol. Dec 1999;19(8 Pt 1):550-5. [Medline].
Cincotta RB, Gray PH, Gardener G, Soong B, Chan FY. Selective fetoscopic laser ablation in 100 consecutive pregnancies with severe twin-twin transfusion syndrome. Aust N Z J Obstet Gynaecol. Feb 2009;49(1):22-7. [Medline].
Chiossi G, Quigley MR, Esaka EJ, Novic K, Celebrezze JU, Golde SH, et al. Nutritional supplementation in monochorionic diamniotic twin pregnancies: impact on twin-twin transfusion syndrome. Am J Perinatol. Nov 2008;25(10):667-72. [Medline].
Brackley KJ, Kilby MD. Twin-twin transfusion syndrome. Hosp Med. Jun 1999;60(6):419-24. [Medline].
Denbow ML, Battin MR, Cowan F, et al. Neonatal cranial ultrasonographic findings in preterm twins complicated bysevere fetofetal transfusion syndrome. Am J Obstet Gynecol. Mar 1998;178(3):479-83. [Medline].
Duncan KR. Twin-to-twin transfusion: update on management options and outcomes. Curr Opin Obstet Gynecol. Dec 2005;17(6):618-22. [Medline].
Elliot JP. Amniocentesis for twin-twin transfusion syndrome. Contemp Ob Gyn. 1992;37:30-47.
[Best Evidence] Fox C, Kilby MD, Khan KS. Contemporary treatments for twin-twin transfusion syndrome. Obstet Gynecol. Jun 2005;105(6):1469-77. [Medline].
Huber A, Diehl W, Bregenzer T, Hackelöer BJ, Hecher K. Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation. Obstet Gynecol. Aug 2006;108(2):333-7. [Medline].
Machin GA, Keith LG. Can twin-to-twin transfusion syndrome be explained, and how is it treated?. Clin Obstet Gynecol. Mar 1998;41(1):104-13. [Medline].
Milner R, Crombleholme TM. Troubles with twins: fetoscopic therapy. Semin Perinatol. Dec 1999;23(6):474-83. [Medline].
Sueters M, Middeldorp JM, Lopriore E, Oepkes D, Kanhai HH, Vandenbussche FP. Timely diagnosis of twin-to-twin transfusion syndrome in monochorionic twin pregnancies by biweekly sonography combined with patient instruction to report onset of symptoms. Ultrasound Obstet Gynecol. Oct 2006;28(5):659-64. [Medline].
Taylor MJ, Govender L, Jolly M, Wee L, Fisk NM. Validation of the Quintero staging system for twin-twin transfusion syndrome. Obstet Gynecol. Dec 2002;100(6):1257-65. [Medline].
Yamamoto M, Ville Y. Recent findings on laser treatment of twin-to-twin transfusion syndrome. Curr Opin Obstet Gynecol. Apr 2006;18(2):87-92. [Medline].
| Stage | Oligohydramnios/ Polyhydramnios | Absent Urine in Donor Bladder | Abnormal Doppler Blood Flows | Hydrops Fetalis | Fetal Demise |
| I | + | - | - | - | - |
| II | + | + | - | - | - |
| III | + | + | + | - | - |
| IV | + | + | + | + | - |
| V | + | + | + | + | + |

